Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patientsMauricette Michallet, Sandrine Hayette, Xavier Thomas et al.|Blood|2008Cited by 0